Related Experiment Video
Updated: May 9, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Digital Therapeutic Content for Substance Use Disorder Treatment: Development and Evaluation Study
Nicholas L Bormann1, Alyssa Kalata1, Stephan Arndt2,3
1Department of Psychiatry and Psychology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, United States, 1 507-284-2511.
Developing digital therapeutics for substance use disorders (SUDs) requires a structured, human-centered approach. This iterative process adapted existing materials, yielding understandable and actionable modules, though actionability varied.
Area of Science:
- Digital Health
- Behavioral Science
- Public Health
Background:
- Substance use disorders (SUDs) present significant public health challenges, with limited uptake of evidence-based interventions.
- Digital therapeutics offer a scalable solution to increase access to SUD treatment.
- Current digital interventions often lack clinician involvement and rigorous development, necessitating validated patient-facing materials.
Purpose of the Study:
- To describe and evaluate an iterative, interdisciplinary process for adapting print-based SUD treatment materials into digital therapeutic modules.
- To assess if a human-centered development approach yields digital modules rated as understandable and actionable.
Main Methods:
- Fourteen existing print modules were adapted for smartphone delivery by a team including licensed counselors with lived experience and a therapeutic specialist.
- Content was restructured, language simplified, and actionability enhanced over a 6-month iterative process.
- Modules were evaluated using the Patient Education Materials Assessment Tool for printable materials (PEMAT-P).
Main Results:
- Digital modules achieved high understandability (mean 87.2%) and actionability (mean 75.1%), exceeding the 70% benchmark.
- While understandability was consistent, 35.7% of modules scored below the actionability threshold.
- Aggregate scores masked variability, indicating that not all content types consistently achieved actionability.
Conclusions:
- An iterative, human-centered process is valuable for developing digital SUD therapeutics.
- While generally effective, the process requires refinement to ensure consistent actionability across all digital modules.
- Incorporating patient feedback during development could further enhance the usability and effectiveness of digital interventions.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Drug Therapy
Antianxiety Medications
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Dependence
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
